Yosprala Alternatives Compared
Yosprala (aspirin / omeprazole) | Atorvastatin | Lipitor (atorvastatin) |
|
---|
Yosprala (aspirin / omeprazole) | Atorvastatin | Lipitor (atorvastatin) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Prevention of Cardiovascular Disease. Yosprala may also be used for purposes not listed in this medication guide. |
Prescription only
Atorvastatin is effective at lowering cholesterol; however, its use may be limited by side effects such as muscle pain. Prescribed for High Cholesterol, High Cholesterol - Familial Homozygous, High... View more |
Prescription only
Lipitor is effective at lowering cholesterol; however, its use may be limited by side effects such as muscle pain. Prescribed for High Cholesterol - Familial Homozygous, High Cholesterol - Familial... View more |
Related suggestions Prevention of Cardiovascular Disease
|
|||||||||||||||
More about Yosprala (aspirin / omeprazole) | More about Atorvastatin | More about Lipitor (atorvastatin) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Atorvastatin has an average rating of 4.4 out of 10 from a total of 303 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 53% reported a negative effect. |
Lipitor has an average rating of 4.3 out of 10 from a total of 102 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 54% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Yosprala side effects |
View all Atorvastatin side effects |
View all Lipitor side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Atorvastatin prices |
View all Lipitor prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Atorvaliq, Lipitor | Other atorvastatin brands include: Atorvaliq | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
10 hours |
14 hours |
14 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 545 drugs are known to interact with Yosprala:
|
A total of 406 drugs are known to interact with Atorvastatin:
|
A total of 406 drugs are known to interact with Lipitor:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
||||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
September 14, 2016 |
December 17, 1996 |
December 17, 1996 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.